Pharma Manufacturing ‘Boom’ high costs, faces potential delays


To date, a new wave of new drug production has less than $ 270 billion.

At least this is what the industry is trying to design.

Accept Johnson & Johnson (JnjAnnounced in March, announced the expansion of existing facilities, $ 55 billion in the next four years. Eli Lilly (Lly), this time, Invested $ 50 billion in Februarywith half of the available plans.

Behind the curtain of Multibillion-Dollar, the promises to be reconstructed, the promises to be reconstructed: If there are new announcements, many have been in work for years.

The reason? A global production trace proved risky thanks to the Coven-19 pandemia. In addition, patent expenses are more likely to be more R & D activities and thus more local production needs. And then there is a demand for people to require higher amounts of medicine.

These are the main reasons for long-term production plans, the presenters began to craft in the last few years.

However, in the first half of the year, the announcements ended with another: The Danger of tariffs from Trump management in importing pharmaceutical goods.

Sandy Romero, Cushman & Wakefield’s Definitions of Life Sciences and HealthCwk“He said:” These tariffs were not like coming, and the opening of plants due to tariffs. “

Most likely, some plans were pushed and greeted this moment to meet the moment to prevent tariffs.

“In fact, when you decide to break the ground … It’s three to five years during planning.”

Lilly is one of those who announce new plans that adapt to Trump’s needs, are currently back in Europe or Asia, the United States.

Lilly CEO David Ricks Earlier Yahoo Finance“I think the goal is to return the supply chain, the threat of tariffs has already been done.”

Especially since $ 270 billion, some companies, experts may have a cancellation for choosing Flashy announcements about some companies plans.

“Classes that have a global supply chain for pharmaceutical and biotechnics and lessons to the supply chain, the lessons that rear the supply chain, focused on regionalization of these supply chains,” he said.

Jimenez said that the generations of drugs living in drugs for chronic and serious diseases spread in the old age groups were more demanded.

Therefore, the plans recently announced are less ties with the efforts to make the Trump’s produced and more of the supply chain and with the needs of drug giants.

Therefore, the United States is preparing to see a flutter of construction and future headlines with it.

Bryan Northrop, Skanska (SKBSY) National Executive Adviser for Science and Technology, Yahoo Financing Ads reported “an important job for all these companies in the United States to carry out the United States in the United States.”

The Deloitte said that the US League President Laks Pernenkil, principle and practice leader, in the current construction projects, in the early construction projects, elections and subsequent tariffs.

At the conference in October, Pernenkil, one of the biggest questions from Pharma leaders, “We all made all these ads, can the construction industry continue at the requesting demand for pike?”

New production ads can be converted to a high-share competition for Pharma companies hoping to get the best teams set to projects.

For years before the announcements, drugs have already viewed the drugs such as space, material expenses and labor.

Probably, the planning, Trump’s tariffs and immigration policies are the cost and time crisis, he said.

Due to the tariffs, growing with the value of steel and aluminum, immigration visa processing, the construction industry feels pain. Romero, total, construction prices have increased by 45% since 2020, after the pandemic, after the post-pandemic.

All this will add to more costs and possible delays.

“If it is difficult to involve people in the workplaces, we can see more breaks and on top of it, the country has a suspension of immigration,” Romero.

Hands of medication techniques, during a regular procedure after the production of drugs, while holding red and black pills and control the red and black pills, the hands taken in a special laboratory.
Hands of medication techniques, during a regular procedure after the production of drugs, while holding red and black pills and control the red and black pills, the hands taken in a special laboratory. · Extreme photographer via Getty Images

“It is a very interesting history of the events that came together,” Arda Ural, Leading American Life Sciences.

Since each company is a different project size and coverage, each company has a different level of exposure.

Therefore, new ads intend to add more pressure to the construction industry.

The Sto Building Group, Deputy Chairman and the Sector of Life Sciences Jennie Taveras, greater cooperation between larger construction companies and small.

“Even the largest builders need help and partners in accelerated times,” he said.

This industrial production plant flies proudly in front of the American Flag-u Flon
This industrial production plant flies proudly in front of the American Flag-u Flon · Amanda Wayne through Getty Images

Will this construction increase in hasty production, even advantage, even the advantage of the US history? This argument.

Legacy Hubs, in the northeastern US, especially included in the Tristate area and Boston; North Carolina’s “Research Triangle”; West Coast; and Chicago. But recently, Ohio, Georgia, Texas and even Florida have grown like potential places for new sites. In the Midwest, Indianapolis, one of the leading blockbuster weight loss medications, the eli lilly increases, zepbound, thanks to the investment.

It is another idea of ​​those facilities, because they need highly qualified labor. However, the labor requirements of these sites, Deloitte’s Pennen, thanks to automation and robotics thanks to the quarter. Thus, perhaps a staff of about 1000, a small percentage should be highly qualified, more than 4,000 needs.

“I don’t think they will go to Legacy Pharma Hub. We will be spread in the United States, which is the leadership of this.”

However, the Skanskan said that Northrop has no probability to spread to states that are no longer at home for at least one site or planned site.

“You can get up a plant in the middle of any earth, because it builds a cheap land and cheap labor unit,” he said. “But if you can’t get the right workforce successfully, it’s not a situation.”

Anjalee Kachmile The hood at Yahoo Finance covers the pharma, insurance, maintenance services, digital health, PBMs and health policies and policies covering everything. Certainly includes GLP-1S. Follow Anjalee like Anjkhem on X, LinkedIn and Bluesky on social media platforms @Anjkhem.

Most recent earnings reports and analysis, savings whispering and expectation to the company and save here





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *